With such high smoking rates among people who experience homelessness or rough sleeping in the UK, this Briefing Paper looks at the potential for tobacco harm reduction to help reduce the health inequalities seen in this vulnerable population.
Tobacco harm reduction consumer advocacy organisations play a vital role in maintaining access to safer nicotine products around the world. Here we explore the development, role and importance of these grassroots groups.
The FCTC COP10 Agenda and supporting documents: implications for the future of tobacco harm reduction
Our latest Briefing Paper looks ahead to the upcoming COP10 meeting in Panama and assesses what the Agenda could mean for the future availability of the safer nicotine products that underpin tobacco harm reduction.
The Framework Convention on Tobacco Control (FCTC) and the Conference of the Parties (COP): an explainer (updated April 2023)
With the Tenth Meeting of the Conference of the Parties (COP) to the Framework Convention on Tobacco Control (FCTC) taking place in November 2023, here's our updated guide to explain how the meeting works. Scroll down to access this document in multiple languages.
Nicotine pouches are a relatively new product which can provide users of high-risk tobacco with an alternative that poses fewer risks to their health. Here we provide an introduction to the tobacco harm reduction potential of this category.
This Briefing Paper summarises The Global State of Tobacco Harm Reduction 2022: The Right Side of History, which charts the history of tobacco harm reduction to date, and considers the future for a strategy that could end smoking.
Used in Scandinavia for more than 200 years, snus is providing smokers in Sweden and Norway with an alternative to combustible cigarettes, but what is it and why is it considered a safer nicotine product? This Briefing Paper aims to provide the answers.
With the number of tobacco users across the continent set to rise by 2025, we look at the current state of tobacco harm reduction in the region, assessing the progress made so far and the obstacles preventing greater adoption of safer nicotine products.
Tobacco harm reduction is not only a potentially life-saving public health intervention for the world’s 1.1 billion smokers, it's also supported by international human rights law. Here we make the case for promoting tobacco harm reduction as a health rights issue.
Tobacco harm reduction is a potentially life-saving intervention for millions of people across the world who use high-risk tobacco products, offering them the chance to switch to a range of safer nicotine products. Here, we provide a detailed introduction to the principles, history and evidence for this vital public health strategy.
The popularity of nicotine vaping products continues to grow around the world as smokers choose to make the switch to safer alternatives and our latest research estimates the global number of vapers increased by 20% between 2020 and 2021.
The WHO Framework Convention on Tobacco Control isn't working. Here we use the key messages from the latest Global State of Tobacco Harm Reduction report, Fighting the Last War, to argue why tobacco harm reduction must be adopted urgently by the WHO.
The Framework Convention on Tobacco Control (FCTC) Conference of the Parties (COP): an explainer (2021)
With the Ninth Meeting of the Conference of the Parties (COP) to the Framework Convention on Tobacco Control (FCTC) taking place from 8 - 13 November 2021, here's our guide to explain how the meeting works.
The UK and tobacco: successful elements of a harm reduction strategy and the chance to influence the international response to smoking
The UK is a world leader in tobacco harm reduction (THR), but it can still do more. Here, we argue COP9 presents the UK with the perfect opportunity to both display its THR credentials on the global stage and to champion the benefits of safer nicotine products.